Click here to view the United Healthcare (UHC) Medical Policy Updates » September 2024 United…
Humana Pharmacy Policy Updates – July 2018
Click here to view the Humana Pharmacy Policy Updates »
July 2018 Pharmacy Policy Updates:
- Angiotensin‐Calcium Channel Blocking Agents
- Aveed® (testosterone undecanoate)
- Aveed® (testosterone undecanoate)
- Bendamustine products (Treanda, Bendeka)
- Berinert® (human C1 inhibitor)
- Bortezomib products (Velcade, bortezomib for injection)
- Brineura™ (cerliponase alfa)
- Carbaglu® (carglumic acid)
- CaroSpir® (spironolactone) oral suspension
- Chenodal® (chenodiol tablets)
- Cholbam® (cholic acid)
- Cimzia® (certolizumab pegol)
- Cimzia® (certolizumab pegol)
- Crysvita® (burosumab‐twza)
- Desvenlafaxine Containing Products
- Effient® (prasugrel)
- Egrifta® (tesamorelin acetate)
- Emend® Oral (aprepitant)
- Empliciti™ (elotuzumab)
- Empliciti™ (elotuzumab)
- Entresto® (sacubitril‐valsartan)
- Entyvio® (vedolizumab)
- Erwinaze® (asparaginase Erwinia chrysanthemi)
- Evzio® (naloxone)
- Firazyr® (icatibant)
- Gilenya® (fingolimod)
- Growth Hormones
- Growth Hormones
- Kalbitor® (ecallantide)
- Keveyis® (dichlorphenamide)
- Khedezla™ (desvenlafaxine ER)
- Minocycline Extended Release
- Nalocet (oxycodone/acetaminophen) tablet
- Namenda® (memantine HCl) and Namenda XR® (memantine HCl extended‐release)
- Northera® (droxidopa)
- Oncaspar® (pegaspargase)
- Pexeva® (paroxetine mesylate)
- Progesterone to Prevent Preterm Birth
- Provigil®
- Provigil®
- Revlimid® (lenalidomide)
- Rituxan® (rituximab)
- RoxyBond™ (oxycodone)
- Rozerem (ramelteon)
- Sabril® (vigabatrin)
- Soliqua™ 100/33 (insulin glargine and lixisenatide), Xultophy® 100/3.6 (insulin degludec and liraglutide)
- Spinraza™ (nusinersen)
- Spritam® (levetiracetam)
- Statin Products
- Synarel® (nafarelin acetate)
- Tavalisse (fostamatinib)
- Tecentriq® (atezolizumab)
- Testopel® (testosterone)
- Topical Testosterone
- Topical Testosterone
- Trisenox® (arsenic trioxide)
- Valchlor® (mechlorethamine)
- Vimpat® (lacosamide)
- Yescarta™ (axicabtagene ciloleucel)
Added 7/23/2018;
- Avastin® (bevacizumab)
- Darzalex® (daratumumab)
- Giazo® (balsalazide disodium)
- Keytruda® (pembrolizumab)
- Probuphine® (buprenorphine) Implant
- Sprycel® (dasatinib)
- Uceris® Tablet and Rectal Foam (budesonide)
- Viberzi® (eluxadoline)
- Zometa® (zoledronic acid)
Click here to view the Humana Pharmacy Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.